Literature DB >> 4053715

Tuberculosis. Cause of death in antibiotic era.

C E Davis, J L Carpenter, C K McAllister, J Matthews, B A Bush, A J Ognibene.   

Abstract

A five-year review (1979 to 1983) of 41 patients with active tuberculosis at the time of death was performed to determine the cause of death. Twenty deaths (49 percent) were directly attributed to tuberculosis. Overwhelming tuberculous disease was the cause of death for seven patients, and among them the majority had strikingly low serum levels of albumin. Ten patients died of either massive hemoptysis or respiratory failure. Only two patients died due to progressive drug-resistant disease in an area where drug resistance is common. The majority of patients (21/41; 51 percent) died of common medical problems unrelated to tuberculosis. Eleven patients died from cardiopulmonary disease (five pulmonary emboli, one respiratory failure due to chronic obstructive pulmonary disease, two acute myocardial infarctions, and two primary dysrhythmias). Three deaths were the result of gastrointestinal bleeding, and three patients died as a result of bacterial superinfection. Our data indicate that patients still die of tuberculosis in the era of effective antituberculosis therapy. It is imperative that clinicians are aware that pulmonary emboli, arteriosclerotic heart disease, bacterial superinfection, and gastrointestinal bleeding cause approximately 50 percent of the deaths among patients who have tuberculosis and that prompt recognition and treatment of those diseases might decrease the mortality from tuberculosis.

Entities:  

Mesh:

Year:  1985        PMID: 4053715     DOI: 10.1378/chest.88.5.726

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  7 in total

1.  Mycobacterium tuberculosis: a continuing cause of sudden and unexpected death in west London.

Authors:  R C Chapman; S M Claydon
Journal:  J Clin Pathol       Date:  1992-08       Impact factor: 3.411

2.  64-detector row CT evaluation of bronchial and non-bronchial systemic arteries in life-threatening haemoptysis.

Authors:  I Ponnuswamy; S T Sankaravadivelu; P Maduraimuthu; K Natarajan; B P Sathyanathan; S Sadras
Journal:  Br J Radiol       Date:  2012-05-17       Impact factor: 3.039

3.  Commentary on: Serum Albumin for Tuberculosis in HIV Infected Patients Eligible for Antiretroviral Therapy.

Authors:  Viroj Wiwanitkit
Journal:  Bioimpacts       Date:  2013-12-02

4.  Deaths in adults with notified pulmonary tuberculosis 1983-5.

Authors:  P Cullinan; S K Meredith
Journal:  Thorax       Date:  1991-05       Impact factor: 9.139

5.  Drug repositioning for anti-tuberculosis drugs: an in silico polypharmacology approach.

Authors:  Sita Sirisha Madugula; Selvaraman Nagamani; Esther Jamir; Lipsa Priyadarsinee; G Narahari Sastry
Journal:  Mol Divers       Date:  2021-09-01       Impact factor: 2.943

Review 6.  Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis.

Authors:  Dick Menzies; Andrea Benedetti; Anita Paydar; Ian Martin; Sarah Royce; Madhukar Pai; Andrew Vernon; Christian Lienhardt; William Burman
Journal:  PLoS Med       Date:  2009-09-15       Impact factor: 11.069

7.  Risk factors related with mortality in patient with pulmonary tuberculosis.

Authors:  Chong Whan Kim; Sang-Ha Kim; Shun Nyung Lee; Seok Jeong Lee; Myoung Kyu Lee; Ji-Ho Lee; Kye Chul Shin; Suk Joong Yong; Won Yeon Lee
Journal:  Tuberc Respir Dis (Seoul)       Date:  2012-07-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.